Online Program

Pathways to lactogenesis: Disruptors and Facilitators

Wednesday, November 6, 2013 : 10:30 a.m. - 10:50 a.m.

Ann Dozier, PhD, University of Rochester, Rochester, NY
Several pathways may explain the relationship between the maternal and infant factors and institutional practices (including maternity care and hospital) that have protective or detrimental effects on lactogenesis, in turn the establishment of adequate milk supply and ultimately BF outcomes. These pathways can be disrupted or delayed by interventions during labor (pharmacologic or mechanical) or supported through early BF initiation, skin-to-skin and hospital practices (such as Baby Friendly's 10-steps). Maternal factors such as smoking, obesity and stress can also interfere with BF thereby moderating the physiologic processes essential for the establishment of mature milk. Other maternal factors such as prior BF, BF intention and BF confidence also affect early BF. The infant may be affected by maternal stress or other maternal or prenatal factors leading to less effective suckling. Furthermore the administration of fluids during labor can lead to maternal postpartum edema (making latch more difficult). Excess fluid in the infant that when lost, may be interpreted as actual weight loss. These events and other clinical and hospital practices can lead to early introduction of formula that can delay or impair lactogenesis and BF outcomes.

Learning Areas:

Public health or related education
Public health or related nursing
Public health or related public policy
Public health or related research

Learning Objectives:
Identify the factors that could positively or negatively influence lactogenesis during the early postpartum period

Keyword(s): Breastfeeding, Children

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have studied breastfeeding for more than 10 years and have organized various sessions related to this topic area for APHA.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.